Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Depression is a known barrier to regimen adherence for chronic conditions. Despite elevated depression rates and complex regimens for people with cystic fibrosis (CF), little is known about associations between depressive symptoms and CF adherence. One possibility is that depressive symptoms distort beliefs about medications, which may influence adherence. METHOD: Adolescents and adults (N = 128; mean age = 29 ± 11 years, range = 16-63, 93% Caucasian) with CF reported on depressive symptoms and medication beliefs (self-efficacy, motivation, perceived importance, and outcome expectancies related to taking medications). Medication adherence was assessed objectively through pharmacy refill data. Cross-sectional structural equation models evaluated medication beliefs as a mediator between depressive symptoms and medication adherence. RESULTS: Twenty-three percent of participants exceeded clinical cutoffs for depressive symptoms. Participants took less than half of prescribed pulmonary medications (mean adherence rate = 44.4 ± 26.7%). Depressive symptoms were correlated with adherence (r = -.22, p < .05), and medication beliefs (b = -0.13, 95% CI [-0.24, -0.03]) significantly mediated this relation. Higher depressive symptoms were associated with less positive medication beliefs (b = -0.27, p < .01), which were associated with lower medication adherence (b = 0.49, p < .01). CONCLUSIONS: Depressive symptoms are related to beliefs about and adherence to CF medications. Monitoring depressive symptoms and medication beliefs in routine CF care may help identify risks for nonadherence and facilitate interventions to reduce depression, adaptive medication beliefs, and ultimately improve adherence and CF management. (PsycINFO Database Record
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hu, L., & Bentler, P. M. (1999) · Structural Equation Modeling A Multidisciplinary Journal · doi:10.1080/10705519909540118 · Cited by 108,788
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358
Horne, R., Chapman, S. C. E., Parham, R., Freemantle, N., Forbes, A., & Cooper, V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080633 · Cited by 1,174
Clarke, D. M., & Currie, K. C. (2009) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02471.x · Cited by 661
Adolescents with a chronic condition: challenges living, challenges treating
Sawyer, S. M., Drew, S., Yeo, M. S., & Britto, M. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60370-5 · Cited by 656
Grenard, J. L., Munjas, B. A., Adams, J. L., Suttorp, M., Maglione, M., McGlynn, E. A., & Gellad, W. F. (2011) · Journal of General Internal Medicine · doi:10.1007/s11606-011-1704-y · Cited by 635 · cited 3×
“Depressive symptoms are known correlates of suboptimal disease management and control (DiMatteo et al., 2000; Grenard et al., 2011), and data from this sample of individuals with CF demonstrated that medication beliefs were of particular relevance and explained a significant portion of the…”
BackgroundHigh treatment burden in adults with cystic fibrosis: challenges to disease self-management
Sawicki, G. S., Sellers, D. E., & Robinson, W. M. (2009) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2008.09.007 · Cited by 498
Impact of major depression on chronic medical illness
Katon, W., & Ciechanowski, P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00313-6 · Cited by 485
Pulmonary medication adherence and health-care use in cystic fibrosis
Quittner, A. L., Zhang, J., Marynchenko, M., Chopra, P. A., Signorovitch, J., Yushkina, Y., & Riekert, K. A. (2014) · Chest · doi:10.1378/chest.13-1926 · Cited by 250 · cited 6×
“Furthermore, the cMPR has been found to be associated with CF health outcomes (Eakin et al., 2011) and health care utilization (Quittner et al., 2014), suggesting that it is a valid construct.”
InfluentialSelf-citationAccurate Assessment of Adherence
Daniels, T., Goodacre, L., Sutton, C., Pollard, K., Conway, S., & Peckham, D. (2011) · Chest · doi:10.1378/chest.09-3074 · Cited by 210 · cited 3×
“The cMPR was selected as an objective assessment of adherence across a range of prescribed pulmonary medications because self-reported adherence has been shown to be highly inaccurate among people with CF (Daniels et al., 2011), and pharmacy-based adherence measures have been recommended for use above self-reported ad…”
Riekert, K. A., Bartlett, S. J., Boyle, M. P., Krishnan, J. A., & Rand, C. S. (2007) · Chest · doi:10.1378/chest.06-2474 · Cited by 197 · cited 1×
“Moderate elevations in depression symptoms (including nearly one quarter with clinically significant symptom levels) were likewise consistent with previously published rates (Goldbeck et al., 2010; Latchford & Duff, 2013; Riekert et al., 2007).”
Self-citationBucks, R. S., Hawkins, K., Skinner, T. C., Horn, S., Seddon, P., & Horne, R. (2009) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsn135 · Cited by 151 · cited 1×
“One small study of adolescents with CF suggested that youths’ perceptions about their illness and treatments were related to self-reported adherence rates (Bucks et al., 2009), suggesting that beliefs about medications may be related to adherence to CF treatments.”
BackgroundSchoenthaler, A., Ogedegbe, G., & Allegrante, J. P. (2009) · Health Education & Behavior · doi:10.1177/1090198107309459 · Cited by 139 · cited 4×
“Evidence of medication beliefs as a mediator indirectly linking depressive symptoms with adherence adds to a growing body of research across chronic conditions (Cha et al., 2008; Cherrington et al., 2010; Schoenthaler et al., 2009) and extends findings to late adolescents and adults with CF.”
MethodResultInfluentialGherman, A., Schnur, J., Montgomery, G., Sassu, R., Veresiu, I., & David, D. (2011) · The Diabetes Educator · doi:10.1177/0145721711403012 · Cited by 122 · cited 2×
“…about treatments or medications have demonstrated associations with poorer adherence among individuals with HIV (Barclay et al., 2007), diabetes (Gherman et al., 2011), sleep apnea (Olsen, Smith, Oei, & Douglas, 2008), hypertension (Quine, Steadman, Thompson, & Rutter, 2012), and those…”
BackgroundAdherence with tobramycin inhaled solution and health care utilization
Briesacher, B. A., Quittner, A. L., Saiman, L., Sacco, P., Fouayzi, H., & Quittell, L. M. (2011) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-11-5 · Cited by 95 · cited 3×
“…Quittner, 2010; Latchford & Duff, 2013; Riekert, Bartlett, Boyle, Krishnan, & Rand, 2007) and adherence to medications and other treatments is notably low (Briesacher et al., 2011; Eakin, Bilderback, Boyle, Mogayzel, & Riekert, 2011; Nasr, Chou, Villa, Chang, & Broder, 2013; Quittner et al., 2014).”
BackgroundEffects of a Tailored Follow-Up Intervention on Health Behaviors, Beliefs, and Attitudes
Jacobs, A. D., Ammerman, A. S., Ennett, S. T., Campbell, M. K., Tawney, K. W., Aytur, S. A., Marshall, S. W., Will, J. C., & Rosamond, W. D. (2004) · Journal of Women's Health · doi:10.1089/1540999041281016 · Cited by 54 · cited 2×
“…that target either depression (Lustman & Clouse, 2002; Safren et al., 2009) or positive beliefs about medication or health (Fumaz et al., 2012; Jacobs et al., 2004; Rawl et al., 2012) have shown promising results in terms of changing beliefs, lifting mood, increasing health behaviors, and/or…”
BackgroundAdherence to dornase alfa treatment among commercially insured patients with cystic fibrosis
Nasr, S. Z., Chou, W., Villa, K. F., Chang, E., & Broder, M. S. (2013) · Journal of Medical Economics · doi:10.3111/13696998.2013.787427 · Cited by 44
Screening for depression in a single CF Centre
Latchford, G., & Duff, A. J. A. (2013) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.04.002 · Cited by 31 · cited 2×
“Like other chronic conditions, the risk for depressive symptoms is elevated (Goldbeck, Besier, Hinz, Singer, & Quittner, 2010; Latchford & Duff, 2013; Riekert, Bartlett, Boyle, Krishnan, & Rand, 2007) and adherence to medications and other treatments is notably low (Briesacher et al., 2011; Eakin,…”
BackgroundResult
Cited by
Quittner, A. L., Abbott, J., Georgiopoulos, A. M., Goldbeck, L., Smith, B., Hempstead, S. E., Marshall, B., Sabadosa, K. A., & Elborn, S. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207488 · Cited by 465
Maintaining mental health and function for the long run in cystic fibrosis
Smith, B. A., Georgiopoulos, A. M., & Quittner, A. L. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23522 · Cited by 39
Catastini, P., Di Marco, S., Furriolo, M., Genovese, C., Grande, A., Iacinti, E., Iusco, D. R., Nobili, R. M. V., Pescini, R., Ragni, R., et al. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23566 · Cited by 36
Yang, C., Hui, Z., Zeng, D., Liu, L., & Lee, D. T. F. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033431 · Cited by 34
Saez-Flores, E., Tonarely, N. A., Barker, D. H., & Quittner, A. L. (2018) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsx155 · Cited by 25
Metadata
- Authors
- Hilliard, M. E., Eakin, M. N., Borrelli, B., Green, A., & Riekert, K. A.
- Venue
- Health Psychology
- Published
- 2015
- Volume
- 34
- Issue
- 5
- Pages
- 496-504
- ISSN
- 0278-6133 (ISSN-L)
- 1930-7810
- OpenAlex
- W2331141523
- Cited by
- 77
- References
- 19
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- green
- Funders
- National Institutes of Health (5R01HL087997)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.